SCHEMBL3653233

SCHEMBL3653233

CCC(N)[SiH2]CCc1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 3/20 0.44
▸ AOC3 Q16853 2/20 0.42
▸ MAOB P27338 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ LOXL2 Q9Y4K0 1/20 0.38
▸ AOC2 O75106 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3506475 0.98 TAAR1 (0.42) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL9075760 0.88 TAAR1 (0.42) TAAR1AOC3MAOBL3MBTL1LOXL2
Hydrochloric Acid SCHEMBL3506519 0.80 LOXL2 (0.39) TAAR1AOC3MAOBLOXL2MAOA
SCHEMBL22129795 0.76 TAAR1 (0.48) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL22129794 0.74 TAAR1 (0.47) TAAR1AOC3MAOBPTGS1PTGS2
SCHEMBL9073941 0.71 TAAR1 (0.40) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL6246687 0.71 TAAR1 (0.52) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL4443662 0.71 TAAR1 (0.52) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL31299585 0.70 TAAR1 (0.50) TAAR1AOC3MAOBL3MBTL1LOXL2
SCHEMBL25824860 0.69 TAAR1 (0.45) TAAR1AOC3MAOBL3MBTL1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195029-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES Oryzon Genomics SA (ES) 2010-06-16 — — EP disclosed
WO-2009027349-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS SA (ES) 2009-03-05 — — WO disclosed
US-5532397-A Substituted silyl alkylene amines MERRELL PHARMACEUTICALS INC. (US) 1996-07-02 — — US disclosed
US-5529988-A Substituted silyl alkylene amines MERRELL PHARMACEUTICALS INC. (US) 1996-06-25 — — US disclosed
US-5384312-A Substituted silyl alkylene amines MERRELL DOW PHARMACEUTICALS INC. (US) 1995-01-24 — — US disclosed
EP-0291787-B1 Novel substituted silyl alkylene amines MERRELL DOW PHARMA (US) 1994-03-16 — — EP disclosed
EP-0291787-A1 Novel substituted silyl alkylene amines MERRELL DOW PHARMACEUTICALS INC. (US) 1988-11-23 — — EP disclosed
Send feedback